Recurrent Shingles Location
Recurrent herpes zoster (shingles) typically occurs in a different dermatome than the initial outbreak, though same-site recurrence can occur in approximately 16% of cases.
Key Evidence on Recurrence Patterns
The most definitive evidence comes from a 2017 Japanese population study tracking 34,877 patients with herpes zoster, where among 1,076 patients who experienced recurrence, only 16.3% had recurrence in the same dermatome 1. This means the vast majority (approximately 84%) of recurrent episodes occur in different locations on the body.
Importantly, genomic analysis from the Shingles Prevention Study demonstrated that when recurrence happens—whether in the same or different dermatome—it is caused by the same VZV strain that established latency throughout multiple sensory ganglia during the original chickenpox infection 2. The virus remains dormant in sensory ganglia throughout the entire body, not just in one location.
Clinical Patterns to Expect
When counseling patients about recurrence risk:
- Overall recurrence rate: Approximately 6-8% of patients will experience a second episode of shingles 1, 3
- Location patterns:
- Different dermatome: ~84% of recurrences
- Same dermatome: ~16% of recurrences
- Contralateral (opposite side) involvement is common when recurrence occurs 2
- Timing: Recurrences can occur anywhere from 3 months to 10+ years after the initial episode 2, 3
Risk Factors for Recurrence
Patients at higher risk for recurrent episodes include 3:
- Women (7.63% vs 4.73% in men)
- Those with prolonged pain (≥30 days) during initial episode (hazard ratio 2.80)
- Immunocompromised individuals (hazard ratio 2.35)
- Age ≥50 years at initial episode
Clinical Implications
The unpredictability of recurrence location means patients cannot assume a second outbreak will spare previously affected areas or necessarily return to the same location. Each reactivation event represents independent viral reactivation from different sensory ganglia where VZV established latency during the original varicella infection.
Vaccination remains important even after experiencing shingles, as the recurrence rate is substantial enough to warrant prevention strategies 4, 5. The recombinant zoster vaccine is recommended for adults ≥50 years regardless of prior herpes zoster history 5.